218 related articles for article (PubMed ID: 17503157)
1. Use of an artificial lymphatic system during carboplatin infusion to improve canine osteosarcoma blood flow and clinical response.
DiResta GR; Aiken SW; Brown HK; Bergman PJ; Hohenhaus A; Ehrhart EJ; Baer K; Healey JH
Ann Surg Oncol; 2007 Aug; 14(8):2411-21. PubMed ID: 17503157
[TBL] [Abstract][Full Text] [Related]
2. Influence of carboplatin infusion on osteosarcoma blood flow.
DiResta GR; Aiken SW; Brown HK; Bergman PJ; Hohenhaus A; Healey JH
Cancer Chemother Pharmacol; 2008 Aug; 62(3):545-9. PubMed ID: 17932675
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a single subcutaneous infusion of carboplatin as adjuvant chemotherapy for dogs with osteosarcoma: 17 cases (2006-2010).
Simcock JO; Withers SS; Prpich CY; Kuntz CA; Rutland BE
J Am Vet Med Assoc; 2012 Sep; 241(5):608-14. PubMed ID: 22916858
[TBL] [Abstract][Full Text] [Related]
4. Palliative radiotherapy with electrons of appendicular osteosarcoma in 54 dogs.
Mueller F; Poirier V; Melzer K; Nitzl D; Roos M; Kaser-Hotz B
In Vivo; 2005; 19(4):713-6. PubMed ID: 15999538
[TBL] [Abstract][Full Text] [Related]
5. Lobaplatin as an adjuvant chemotherapy to surgery in canine appendicular osteosarcoma: a phase II evaluation.
Kirpensteijn J; Teske E; Kik M; Klenner T; Rutteman GR
Anticancer Res; 2002; 22(5):2765-70. PubMed ID: 12529994
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable cisplatin polymer in limb-sparing surgery for canine osteosarcoma.
Withrow SJ; Liptak JM; Straw RC; Dernell WS; Jameson VJ; Powers BE; Johnson JL; Brekke JH; Douple EB
Ann Surg Oncol; 2004 Jul; 11(7):705-13. PubMed ID: 15231525
[TBL] [Abstract][Full Text] [Related]
7. Hemorrhagic cystitis in a dog receiving carboplatin.
MacDonald V; Dickinson R
J Am Anim Hosp Assoc; 2014; 50(1):67-70. PubMed ID: 24216493
[TBL] [Abstract][Full Text] [Related]
8. Carboplatin versus alternating carboplatin and doxorubicin for the adjuvant treatment of canine appendicular osteosarcoma: a randomized, phase III trial.
Skorupski KA; Uhl JM; Szivek A; Allstadt Frazier SD; Rebhun RB; Rodriguez CO
Vet Comp Oncol; 2016 Mar; 14(1):81-7. PubMed ID: 24118677
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of octreotide pamoate long-acting release and carboplatin versus carboplatin alone in dogs with naturally occurring osteosarcoma: evaluation of insulin-like growth factor suppression and chemotherapy.
Khanna C; Prehn J; Hayden D; Cassaday RD; Caylor J; Jacob S; Bose SM; Hong SH; Hewitt SM; Helman LJ
Clin Cancer Res; 2002 Jul; 8(7):2406-12. PubMed ID: 12114446
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of toxicities from combined metronomic and maximal-tolerated dose chemotherapy in dogs with osteosarcoma.
Bracha S; Walshaw R; Danton T; Holland S; Ruaux C; Obradovich J
J Small Anim Pract; 2014 Jul; 55(7):369-74. PubMed ID: 24803081
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine kinase inhibitor sorafenib decreases cell number and induces apoptosis in a canine osteosarcoma cell line.
Wolfesberger B; Tonar Z; Gerner W; Skalicky M; Heiduschka G; Egerbacher M; Thalhammer JG; Walter I
Res Vet Sci; 2010 Feb; 88(1):94-100. PubMed ID: 19665156
[TBL] [Abstract][Full Text] [Related]
12. STEALTH liposome-encapsulated cisplatin (SPI-77) versus carboplatin as adjuvant therapy for spontaneously arising osteosarcoma (OSA) in the dog: a randomized multicenter clinical trial.
Vail DM; Kurzman ID; Glawe PC; O'Brien MG; Chun R; Garrett LD; Obradovich JE; Fred RM; Khanna C; Colbern GT; Working PK
Cancer Chemother Pharmacol; 2002 Aug; 50(2):131-6. PubMed ID: 12172978
[TBL] [Abstract][Full Text] [Related]
13. Blood vessel density in canine osteosarcoma.
Coomber BL; Denton J; Sylvestre A; Kruth S
Can J Vet Res; 1998 Jul; 62(3):199-204. PubMed ID: 9684049
[TBL] [Abstract][Full Text] [Related]
14. The effects of taurolidine alone and in combination with doxorubicin or carboplatin in canine osteosarcoma in vitro.
Marley K; Helfand SC; Edris WA; Mata JE; Gitelman AI; Medlock J; Séguin B
BMC Vet Res; 2013 Jan; 9():15. PubMed ID: 23331343
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant carboplatin and gemcitabine combination chemotherapy postamputation in canine appendicular osteosarcoma.
McMahon M; Mathie T; Stingle N; Romansik E; Vail D; London C
J Vet Intern Med; 2011; 25(3):511-7. PubMed ID: 21488959
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant therapy with carboplatin and pamidronate for canine appendicular osteosarcoma.
Kozicki AR; Robat C; Chun R; Kurzman ID
Vet Comp Oncol; 2015 Sep; 13(3):229-36. PubMed ID: 23663234
[TBL] [Abstract][Full Text] [Related]
17. Alternating carboplatin and doxorubicin as adjunctive chemotherapy to amputation or limb-sparing surgery in the treatment of appendicular osteosarcoma in dogs.
Kent MS; Strom A; London CA; Seguin B
J Vet Intern Med; 2004; 18(4):540-4. PubMed ID: 15320595
[TBL] [Abstract][Full Text] [Related]
18. Toxicity and efficacy of cisplatin and doxorubicin combination chemotherapy for the treatment of canine osteosarcoma.
Chun R; Garrett LD; Henry C; Wall M; Smith A; Azene NM
J Am Anim Hosp Assoc; 2005; 41(6):382-7. PubMed ID: 16267062
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of metronomic cyclophosphamide chemotherapy as maintenance treatment for dogs with appendicular osteosarcoma following limb amputation and carboplatin chemotherapy.
Matsuyama A; Schott CR; Wood GA; Richardson D; Woods JP; Mutsaers AJ
J Am Vet Med Assoc; 2018 Jun; 252(11):1377-1383. PubMed ID: 29772973
[TBL] [Abstract][Full Text] [Related]
20. Adverse events and outcomes in dogs with appendicular osteosarcoma treated with limb amputation and a single subcutaneous infusion of carboplatin.
Santamaria AC; Simcock JO; Kuntz CA
J Am Vet Med Assoc; 2019 Aug; 255(3):345-351. PubMed ID: 31298641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]